Zhenwei Deng

526 total citations
20 papers, 378 citations indexed

About

Zhenwei Deng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhenwei Deng has authored 20 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhenwei Deng's work include Gastric Cancer Management and Outcomes (5 papers), RNA modifications and cancer (4 papers) and Immunotherapy and Immune Responses (4 papers). Zhenwei Deng is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), RNA modifications and cancer (4 papers) and Immunotherapy and Immune Responses (4 papers). Zhenwei Deng collaborates with scholars based in China. Zhenwei Deng's co-authors include Xiguang Chen, Ya Liu, Cong-Shan Yuan, Ting Wang, Yuxin Tang, Yuzhi Mu, Di Qin, Libo Li, Ruiping Li and Na Wang and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Zhenwei Deng

20 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenwei Deng China 10 144 97 94 73 70 20 378
Zhengmao Lu China 12 161 1.1× 67 0.7× 83 0.9× 35 0.5× 65 0.9× 29 373
Yangchun Zhou China 9 328 2.3× 82 0.8× 160 1.7× 120 1.6× 90 1.3× 11 516
Yusuke Ohara Japan 11 152 1.1× 53 0.5× 80 0.9× 95 1.3× 68 1.0× 53 465
Zhengmao Lu China 10 151 1.0× 84 0.9× 48 0.5× 53 0.7× 65 0.9× 19 324
Dongbing Ding China 12 147 1.0× 58 0.6× 140 1.5× 58 0.8× 92 1.3× 20 509
Yahui Liu China 10 141 1.0× 32 0.3× 223 2.4× 125 1.7× 55 0.8× 29 435
Yuejiao Zhong China 14 254 1.8× 153 1.6× 130 1.4× 139 1.9× 94 1.3× 32 576
Jiaai Wang United States 9 156 1.1× 29 0.3× 90 1.0× 33 0.5× 38 0.5× 15 386
Yongbin Zheng China 12 204 1.4× 171 1.8× 38 0.4× 20 0.3× 80 1.1× 33 471
Wen Song China 11 226 1.6× 147 1.5× 108 1.1× 88 1.2× 96 1.4× 34 500

Countries citing papers authored by Zhenwei Deng

Since Specialization
Citations

This map shows the geographic impact of Zhenwei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Deng more than expected).

Fields of papers citing papers by Zhenwei Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenwei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Deng. The network helps show where Zhenwei Deng may publish in the future.

Co-authorship network of co-authors of Zhenwei Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenwei Deng. A scholar is included among the top collaborators of Zhenwei Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenwei Deng. Zhenwei Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Zhenwei, Jianke Yang, Tingjie Zhang, et al.. (2024). Long-term combined blockade of CXCR4 and PD-L1 with in vivo reassembly for intensive tumor interference. Journal of Controlled Release. 370. 453–467. 1 indexed citations
2.
Pan, Ting, Guohao Chen, Yuxin Tang, et al.. (2022). LncRNA NORAD mediates KMT2D expression by targeting miR-204-5p and affects the growth of gastric cancer. Journal of Gastrointestinal Oncology. 13(6). 2832–2844. 6 indexed citations
3.
Wang, Ting, Zheng He, Cong-Shan Yuan, et al.. (2022). MMP-responsive transformation nanomaterials with IAP antagonist to boost immune checkpoint therapy. Journal of Controlled Release. 343. 765–776. 20 indexed citations
4.
Wang, Na, et al.. (2022). Exploiting autophagy-regulative nanomaterials for activation of dendritic cells enables reinforced cancer immunotherapy. Biomaterials. 282. 121434–121434. 34 indexed citations
5.
Deng, Zhenwei, Cong-Shan Yuan, Ting Wang, Xiguang Chen, & Ya Liu. (2021). Peptide-based assemblies as immune checkpoint inhibitor delivery systems for enhanced immunotherapy. Applied Materials Today. 23. 101063–101063. 7 indexed citations
6.
Yuan, Cong-Shan, Zhenwei Deng, Di Qin, et al.. (2021). Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?. Acta Biomaterialia. 125. 1–28. 56 indexed citations
7.
Jian, Xing, et al.. (2021). Palladium-catalyzed and alcohol-enabled transformation to synthesize benzocyclic ketones. Organic & Biomolecular Chemistry. 19(46). 10210–10214. 3 indexed citations
8.
Yang, Feng, Xiaoting Chen, Jianhua Chen, et al.. (2020). <p>Long Intergenic Non-Protein Coding RNA 1089 Suppresses Cell Proliferation and Metastasis in Gastric Cancer by Regulating miRNA-27a-3p/Epithelial–Mesenchymal Transition (EMT) Axis</p>. Cancer Management and Research. Volume 12. 5587–5596. 6 indexed citations
9.
Deng, Zhenwei, Huaiming Wang, Yuxin Tang, et al.. (2020). Dysregulation of CircRNA_0001946 Contributes to the Proliferation and Metastasis of Colorectal Cancer Cells by Targeting MicroRNA-135a-5p. Frontiers in Genetics. 11. 357–357. 33 indexed citations
10.
Deng, Zhenwei, Ting Wang, Xiguang Chen, & Ya Liu. (2020). Applications of chitosan-based biomaterials: a focus on dependent antimicrobial properties. Marine Life Science & Technology. 2(4). 398–413. 47 indexed citations
11.
Deng, Zhenwei, Huaiming Wang, Yuxin Tang, et al.. (2019). Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901. Medical Science Monitor. 25. 2386–2396. 7 indexed citations
12.
Gao, Meng, et al.. (2019). Failure Mode Analysis of Terminal Guidance Projectile. 51–56. 1 indexed citations
13.
Wang, Huaiming, Zhenwei Deng, Xinhua Chen, et al.. (2019). Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein. Medical Science Monitor. 25. 2169–2178. 20 indexed citations
14.
Xiong, Wenjun, et al.. (2018). Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer. Biochemical and Biophysical Research Communications. 504(1). 129–136. 33 indexed citations
15.
Ren, Haotang, et al.. (2018). Rab3IP interacts with SSX2 and enhances the invasiveness of gastric cancer cells. Biochemical and Biophysical Research Communications. 503(4). 2563–2568. 9 indexed citations
16.
17.
Yan, Jun, Xiaoling Zheng, Zhangyuanzhu Liu, et al.. (2015). A multicenter study of using carbon nanoparticles to show sentinel lymph nodes in early gastric cancer. Surgical Endoscopy. 30(4). 1294–1300. 36 indexed citations
18.
Hu, Yanfeng, Da Wang, Lin Tian, et al.. (2015). An automatically contamination-avoiding technique for intracorporeal esophagojejunostomy using a transorally inserted anvil during laparoscopic total gastrectomy for gastric cancer. World Journal of Surgical Oncology. 13(1). 154–154. 4 indexed citations
19.
Yan, Jun, Fangqin Xue, Hong‐Yuan Chen, et al.. (2014). A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1–2 colorectal cancer. Surgical Endoscopy. 28(12). 3315–3321. 31 indexed citations
20.
Zou, Zhenhong, Tingyu Mou, Zhenwei Deng, Yuming Jiang, & Guoxin Li. (2014). [Exploration of digestive tract reconstruction with totally laparoscopic total gastrectomy for gastric cancer].. PubMed. 17(8). 844–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengmao Lu Breakdown of academic impact, for papers by Yangchun Zhou Breakdown of academic impact, for papers by Yusuke Ohara Breakdown of academic impact, for papers by Zhengmao Lu Breakdown of academic impact, for papers by Dongbing Ding Breakdown of academic impact, for papers by Yahui Liu Breakdown of academic impact, for papers by Yuejiao Zhong Breakdown of academic impact, for papers by Jiaai Wang Breakdown of academic impact, for papers by Yongbin Zheng Breakdown of academic impact, for papers by Wen Song
Rankless by CCL
2026